Výsledky vyhledávání - "Jason Kwok Kong Loh"

Polymer-free biolimus-A9-coated stent for primary percutaneous coronary intervention

Autor: Timothy James Watson, Jason Kwok Kong Loh, D. J. H. Lee, F. H. Jafary, Paul Jl. Ong, H.-P. Stoll, Hee Hwa Ho

Publikováno v: Herz. 44:750-755

The polymer-free biolimus-A9 drug-coated stent (DCS) was reported to have superior safety and efficacy outcomes compared with a bare metal stent in the LEADERS FREE trial of high-bleeding-risk patients with acute coronary syndrome and on dual antipla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb8b6b95f7b8443e806f3e52bc000d1
https://doi.org/10.1007/s00059-018-4701-7

Zobrazit plný text záznamu

Long-term Clinical and Cost Outcomes of a Pharmacist-managed Risk Factor Management Clinic in Singapore: An Observational Study

Autor: Kwee Keng Kng, Jason Kwok Kong Loh, Sze Mian Lim, Alexandre Chan, Joyce Yu-Chia Lee, She Hui Tan

Publikováno v: Clinical Therapeutics. 39:2355-2365

Purpose Few studies have determined the benefits of pharmacist-run clinics within a tertiary institution, and specifically on their capability to improve clinical outcomes as well as reduce the cost of illness. This study was designed to investigate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bee3470b4e478954756289d1926907b
https://doi.org/10.1016/j.clinthera.2017.10.009

Zobrazit plný text záznamu

Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease

Autor: Thuzar Tint Nyein, Fahim Haider Jafary, Dasdo Antonius Sinaga, Jason Kwok Kong Loh, Alyssa Sim, Hee Hwa Ho, Timothy James Watson, Paul Jau Lueng Ong, Yau Wei Ooi, Julian K.B. Tan

Publikováno v: Journal of Interventional Cardiology. 29:454-460

Background Drug-coated balloons (DCB) have been used to treat de novo small vessel coronary disease (SVD), with promising results and shorter dual antiplatelet therapy (DAPT) duration compared to drug-eluting stents (DES). We compared safety and effe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d878e5bc9579c636905f8c3d8ef3887
https://doi.org/10.1111/joic.12333

Zobrazit plný text záznamu

Plný text ve formátu HTML

Treatment with 48-mm everolimus-eluting stents : Procedural safety and 12-month patient outcome

Autor: Paul Jl. Ong, Fahim Haider Jafary, Z L Tin, Jason Kwok Kong Loh, T. Watson, Hee Hwa Ho, Mohd Kamal Mohd Arshad, C K Tan

Publikováno v: Herz. 44(5)

Lesion length is a major predictor of adverse outcomes after percutaneous coronary intervention. Long lesions often require multiple stents with variable overlap, which increases the probability of geographical miss and the incidence of mechanical co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8d0f589391120b445f7884cc5b933a3
https://pubmed.ncbi.nlm.nih.gov/29340719

Zobrazit plný text záznamu

TCTAP A-104 Clinical Outcomes of Amphilimus Drug Eluting Stents in an All-comers Southeast Asian Registry

Autor: Dasdo Antonius Sinaga, Timothy James Watson, Mohd Kamal Mohd Arshad, Fahim Haider Jafary, Paul Jl. Ong, Deanna Zhi-Lin Khoo, Hee Hwa Ho, Sazzli Kasim, Jason Kwok Kong Loh, Simon Soo Siong Lo

Publikováno v: Journal of the American College of Cardiology. 71:S57-S58

Amphilimus-eluting stent (AES) is a novel polymer-free drug-eluting stent (DES) that combines sirolimus with fatty acid as anti-proliferative drug and has shown promising results in the percutaneous coronary intervention (PCI). There is limited data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e879c825bb3e4db06635fdd8f0d94c14
https://doi.org/10.1016/j.jacc.2018.03.179

Zobrazit plný text záznamu

TCTAP A-030 1-year Clinical Outcomes of Patients Treated with 48 mm Everolimus Eluting Stent in Primary Percutaneous Coronary Intervention

Autor: Paul Jau Lueng Ong, Deanna Zhi-Lin Khoo, Jin Hyun Lee, Hee Hwa Ho, Jia Min Chua, Jason Kwok Kong Loh, Fahim Haider Jafary

Publikováno v: Journal of the American College of Cardiology. 73:S15

Primary percutaneous coronary intervention (PPCI) with new generation drug-eluting stents (DES) is the preferred reperfusion therapy for ST-elevation myocardial infarction (STEMI). For patients with long de novo coronary artery disease, outcomes rema

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::004dd88bb0d4d253f98cfb148718b1a6
https://doi.org/10.1016/j.jacc.2019.03.056

Zobrazit plný text záznamu

Drug coated balloon angioplasty in elderly patients with small vessel coronary disease

Autor: Paul Jau Lueng Ong, Uwe Zeymer, Hee Hwa Ho, Matthias Waliszewski, Julian K.B. Tan, Fahim Haider Jafary, Yau Wei Ooi, Jason Kwok Kong Loh, Dasdo Antonius Sinaga

Publikováno v: Therapeutic advances in cardiovascular disease. 9(6)

Background: Coronary angioplasty in advanced age is associated with higher rate of comorbidities and complications. Drug coated balloon only angioplasty (DCBA) has emerged as an alternative to treat small vessel coronary disease (SVCD), of reference

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e323253eef98445d5cf05bdcb2cc7d9
https://pubmed.ncbi.nlm.nih.gov/26265774

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání